Tech · Kalshi
Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2028?
Trade on Kalshi →43.50%
39.55% fee-adjusted
Executive Briefing
Live Kalshi consensus prices "No" at 56.5% on "Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2028?", backed by $469 in 24h trading volume.
Stats
- 24h Volume
- $469
- Momentum
- +0.00pt/day
Compare Across Platforms
Not listed on another platform we track (or no confident match found).
Other Tech Markets
Frequently Asked Questions
What is the current probability for "Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2028?"?
As of the latest update, Kalshi prices this at 43.50%, based on $469 in tracked 24h trading volume.
When does this market close?
This contract is scheduled to resolve on or around January 1, 2028, per Kalshi's listed close time.
Where can I trade this market?
This contract trades live on Kalshi. You can view the live order book and trade it directly at the source link on this page.
Is this market listed on other prediction platforms?
Not currently listed on another platform PredictRankd tracks (Polymarket, Manifold, PredictIt, Limitless, Smarkets, Futuur), or no confidently-verified match was found.